What this study is
This study collects and stores blood and tumor samples from patients with malignant melanoma and healthy individuals. The purpose of this study is to gain a better understanding of the causes of melanoma and how melanoma tumors behave. Storing blood and tumor samples for future research may lead to new discoveries that may ultimately help with diagnosing or treating this disease.
What's being tested
- Biospecimen Collection
Intervention · PROCEDURE
Undergo collection of blood and tissue samples
Study details
- Official title
- Analysis of the Tumor Microenvironment and Immune Response in Malignant Melanoma
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Conditions
- Melanoma
- Enrolling
- 1,000 people
- Starts
- 2013-05-07
- Est. completion
- 2027-10-31
- Record
- View on ClinicalTrials.gov ↗
Who can join
Sex ALLHealthy volunteers AcceptedYou may qualify if
- Patient with malignant melanoma or personal history of melanoma
- Normal donors
- Informed consent can be obtained
- Patients with any stage of malignant melanoma
You can't join if
- Incarcerated individuals will be excluded from this protocol
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openOhio State University Comprehensive Cancer Center
Columbus, Ohio, United States
- William E. Carson, MD · Contact614-293-6306
- William E. Carson, MD · Principal investigator
Recruiting
Study team
Sponsor
Ohio State University Comprehensive Cancer Center
Study ID OSU-13114
Principal investigator
William E Carson, MD
Ohio State University Comprehensive Cancer Center
CONTACT
The Ohio State University Comprehensive Cancer Center
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.